Pregestational diabetes

Obstetrics and Gynecology Clinics of North America

Volumn 37, Issue 2, 2010, Pages 143-158

  Pridjian, Gabriella ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes type 1; Diabetes type 2; Pregnancy

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ANTIDIABETIC AGENT;

ARTICLE; BEDTIME DOSAGE; BLOOD GLUCOSE MONITORING; CORONARY ARTERY DISEASE; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET RESTRICTION; DIET THERAPY; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG SAFETY; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTRAPARTUM CARE; KINESIOTHERAPY; MATERNAL CARE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SHOULDER DYSTOCIA; THIRD TRIMESTER PREGNANCY; TREATMENT INDICATION; WEIGHT REDUCTION; CLASSIFICATION; DIABETES MELLITUS; DIET; FEMALE; FETUS DISEASE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; METABOLISM; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR;

BLOOD GLUCOSE; DIABETES MELLITUS; DIET; FEMALE; FETAL DISEASES; GESTATIONAL AGE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY IN DIABETICS; RISK FACTORS;

EID: 79952012700     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2010.02.014     Document Type: Article

References (65)

1. Narayan KM, Boyle JP, Geiss LS, et al. Impact of recent increase in incidence on future diabetes burden. Diabetes Care 2006;29(9):2114-6.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-7.
3. The DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66.
4. Dabelea D. The accelerating epidemic of childhood diabetes. Lancet 2009;373: 2027-33.
5. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36(3):267-8.
6. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2009;300(24):2886-97.
7. White P. Classification of obstetric diabetes. Am J Obstet Gynecol 1978;130: 228-30.
8. Haeri S, Khoury J, Kovilam O, et al. The association of intrauterine growth abnormalities in women with type 1 diabetes mellitus complicated by vasculopathy. Am J Obstet Gynecol 2008;199:278 e1-5.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33(Suppl 1):S62-9.
10. Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 1991; 165:1667-72.
11. Sivan E, Chen X, Homko, et al. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care 1997;20:1470-5.
12. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008;31:S12-54.
13. Jovanovic L, Peterson CM. Dietary manipulation as a primary treatment strategy for pregnancies complicated by diabetes. J Am Coll Nutr 1990;9: 320-5.
14. Obesity in pregnancy, ACOG Committee Opinion No. 315. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;106:671-5.
15. Jovanovic L, Ilic S, Pettitt DJ, et al. The metabolic and immunologic effects of insulin lispro in gestational diabetes. Diabetes Care 1999;22:1422-6.
16. Home PD, Lindholm A, Hylleberg B, et al. Improved glycemic control with insulin aspart: a multi-center randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group. Diabetes Care 1998;21: 1904-9.
17. Singh C, Jovanovic L. Insulin analogues in the treatment of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:275-91.
18. Rosenstock J, Dailey G, Massi-Benedetti M, et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care 2005;28:950-5.
19. Horvath K, Jeitler K, Berghold A, et al. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. The Cochrane Library 2009;2:CD005613. DOI:10.1002/14651858.CD005613.pub3.
20. Egerman RS, Ramsey RD, Kao LW, et al. Perinatal outcomes in pregnancies managed with antenatal insulin glargine. Am J Perinatol 2009;26(8):591-5.
21. Henderson CE, Machipalli S, Marcano-Vasquez H, et al. A retrospective review of glargine use in pregnancy. J Reprod Med 2009;54(4):208-10.
22. Fang YM, MacKeen D, Egan JF, et al. Insulin glargine compared with neutral protamine Hagedorn insulin in the treatment of pregnant diabetics. J Matern Fetal Neonatal Med 2009;22(3):249-53.
23. Gallen IW, Jaap A, Roland, et al. Survey of glargine use in 115 pregnant women with type 1 diabetes. Diabet Med 2008;25:165-9.
24. Mukhopadhyay A, Farrell T, Fraser RB, et al. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007;197:447-56.
25. Gabbe SG, Holing E, Temple P, et al. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000;182:1283-91.
26. Yogev Y, Hod M. Use of new technologies for monitoring and treating diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:241-53.
27. Murphy HR, Rayman G, Lewis K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ 2008;337: a1680.
28. McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007;47(3):186-90.
29. Jovanovic R, Jovanovic L. Obstetric management when normoglycemia is maintained in diabetic pregnant women with vascular compromise. Am J Obstet Gynecol 1984;149:617-23.
30. Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term followup associated with modern management of diabetic nephropathy (Class F). Obstet Gynecol 1996;87:401-9.
31. Feig DS, Razzaq A, Sykora K, et al. Trends in deliveries, prenatal care, and obstetrical complications in women with pregestational diabetes: a populationbased study in Ontario, Canada, 1996-2001. Diabetes Care 2006;29:232-5.
32. Ravid M, Brosh D, Levi Z, et al. Use of Enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. Ann Intern Med 1998;128:982-8.
33. Kasiske BL, Kalil RS, Ma JZ, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993;118: 129-38.
34. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first trimester exposure to ACE inhibitors. N Engl J Med 2006;354: 2443-51.
35. Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy. Am J Obstet Gynecol 1992;166:1214-8.
36. Laatikainen L, Larinkari J, Teramo K, et al. Occurrence and prognostic significance of retinopathy in diabetic pregnancy. Metab Pediatr Ophthalmol 1980;4:191-5.
37. Rosenn BM, Miodovnk J. Medical complications of diabetes mellitus in pregnancy. Clin Obstet Gynecol 2000;43:17-31.
38. Chew EY, Mills JL, Metzger BE, et al. for the National Institute of Child Health and Human Development-diabetes in early pregnancy study. Metabolic control and progression of retinopathy: the diabetes in early pregnancy study. Diabetes Care 1995;18:631-7.
39. Lovestam-Adrian M, Agardh CD, Aberg A, et al. Pre-eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type I diabetic patients. Diabet Med 1997;14:1059-65.
40. Kaaja R, Loukovaara S. Progression of retinopathy in type 1 diabetic women during pregnancy. Curr Diabetes Rev 2007;3:85-93.
41. Grunwald JE, DuPont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996;80:327-31.
42. Chang S, Fuhrmann M, Jovanovich L. The diabetes in early pregnancy study group (DIEP): pregnancy, retinopathy normoglycemia. A preliminary analysis. Diabetes 1985;35(Suppl):3A.
43. Hemachandra A, Ellis D, Lloyd CE, et al. The influence of pregnancy on IDDM complications. Diabetes Care 1995;18:950-4.
44. Montoro MN, Myers VP, Mestman JH, et al. Outcome of pregnancy in diabetic ketoacidosis. Am J Perinatol 1993;10:17-20.
45. Gabbe SG, Carpenter LB, Garrison EA. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy. Clin Obstet Gynecol 2007;50:1014-24.
46. Carroll MA, Yeomans ER. Diabetic ketoacidosis in pregnancy. Crit Care Med 2005;339:S347-53.
47. Schneider MB, Umpierrez GE, Ramsey RD, et al. Pregnancy complicated by diabetic ketoacidosis, maternal and fetal outcomes. Diabetes Care 2003;26: 958-9.
48. Miller E, Hare JW, Cloherty JP, et al. Elevated maternal hemoglobin A1c in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981;304:1331-4.
49. Mills JL, Baker L, Goldman A. Malformations in infants of diabetic mothers occur before the seventh gestational week: implications for treatment. Diabetes 1979; 23:292-3.
50. Schaefer-Graf UM, Buchanan TA, Xiang A, et al. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000;182: 313-20.
51. Steel JM, Johnstone FD, Hepburn DA, et al. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 1990;301:1070-4.
52. Willhoite MB, Bennert HW, Palomaki GE, et al. The impact of preconception counseling in pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993;16:450-5.
53. Mondestin MA, Ananth CV, Sumulian JC, et al. Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol 2002;187:922-6.
54. Dudly D. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin 2007;34:293-307.
55. Bradley RJ, Brudenell JM, Nicolaides KH. Fetal acidosis and hyperlacticaemia diagnosed by cordocentesis in pregnancies complicated by maternal diabetes mellitus. Diabet Med 1991;8:464-8.
56. Kjos SL, Leung A, Henry OA, et al. Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor. Am J Obstet Gynecol 1995;173: 1532-9.
57. Balsells M, Garcia-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab 2009;94(11):4284-91.
58. Langer O, Anyaegbunam A, Brustman L, et al. Pregestational diabetes: insulin requirements throughout pregnancy. Am J Obstet Gynecol 1988;159: 616-21.
59. Jovanovic L, Mils JL, Knopp RH, et al. The National Institute of Child Health and Human Development-Diabetes in Early Pregnancy Study Group. Declining insulin requirements in the late first trimester of diabetic pregnancy. Diabetes Care 2001;24:1130-6.
60. Nielsen LR, Johansen M, Pedersen-Bjergaard U, et al. Predictors and role of metabolic control. Diabetes Care 2009;31:9-14.
61. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital heart defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
62. Barrett JM, Salyer SL, Boehm FH. The nonstress test: an evaluation of 1000 patients. Am J Obstet Gynecol 1981;141:153-8.
63. Curet LB, Izquierdo LA, Gilson GJ, et al. Relative effects of antepartum and intrapartum maternal blood glucose levels on incidence of neonatal hypoglycemia. J Perinatol 1997;17:113-5.
64. Sadauskaite-Kuehne V, Ludvigsson J, Padaiga Z, et al. Longer breastfeeding is an independent protective factor against development of type 1 diabetes mellitus in childhood. Diabetes Metab Res Rev 2004;20:150-7.
65. Stuebe AM, Rish-Edwards JW, Willett WC, et al. Duration of lactation and incidence of type 2 diabetes. JAMA 2005;294(20):2601-10.